The DOI matches its Crossref record; 63 of the 63 references it cites were found in a registry or an index.
Targeting mi R‐155 restores abnormal microglia and attenuates disease in SOD 1 mice
Open accessAbstract
Objective: To investigate miR‐155 in the SOD1 mouse model and human sporadic and familial amyotrophic lateral sclerosis (ALS). Methods: NanoString microRNA, microglia and immune gene profiles, protein mass spectrometry, and RNA‐seq analyses were measured in spinal cord microglia, splenic monocytes, and spinal cord tissue from SOD1 mice and in spinal cord tissue of familial and sporadic ALS. miR‐155 was targeted by genetic ablation or by peripheral or centrally administered anti–miR‐155 inhibitor in SOD1 mice. Results: In SOD1 mice, we found loss of the molecular signature that characterizes homeostatic microglia and increased expression of miR‐155. There was loss of the microglial molecules P2ry12, Tmem119, Olfml3, transcription factors Egr1, Atf3, Jun, Fos, and Mafb, and the upstream regulators Csf1r, Tgfb1, and Tgfbr1, which are essential for microglial survival. Microglia biological functions were suppressed including phagocytosis. Genetic ablation of miR‐155 increased survival in SOD1 mice by 51 days in females and 27 days in males and restored the abnormal microglia and monocyte molecular signatures. Disease severity in SOD1 males was associated with early upregulation of inflammatory genes, including Apoe in microglia. Treatment of adult microglia with apolipoprotein E suppressed the M0‐homeostatic unique microglia signature and induced an M1‐like phenotype. miR‐155 expression was increased in the spinal cord of both familial and sporadic ALS. Dysregulated proteins that we identified in human ALS spinal cord were restored in SOD1 G93A/miR‐155−/− mice. Intraventricular anti–miR‐155 treatment derepressed microglial miR‐155 targeted genes, and peripheral anti–miR‐155 treatment prolonged survival. Interpretation: We found overexpression of miR‐155 in the SOD1 mouse and in both sporadic and familial human ALS. Targeting miR‐155 in SOD1 mice restores dysfunctional microglia and ameliorates disease. These findings identify miR‐155 as a therapeutic target for the treatment of ALS. ANN NEUROL 2015;77:75–99
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“It has been reported that peripheral administration of anti-miR155 in SOD1 mice reversed this abnormal phenotype of microglia and ameliorated the disease [6].”
From Loss of homeostatic microglial phenotype in CSF1R-related Leukoencephalopathy (2020) · cites this paper as [6]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Loss of the M0-homeostatic microglial signature in animal models of amyotrophic lateral sclerosis (ALS) is associated with up-regulation of inflammatory genes, which correlates with disease severity [6].”
From Loss of homeostatic microglial phenotype in CSF1R-related Leukoencephalopathy (2020) · cites this paper as [6]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In ALS (B6/SJL-SOD1G93A transgenic) mice it has been shown that germ-line knock-out of miR-155 altered microglia polarization in vivo [46].”
From Microglia specific deletion of miR-155 in Alzheimer’s disease mouse models reduces amyloid-β pathology but causes hyperexcitability and seizures (2023) · cites this paper as [46]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Increased expression of miR-155, with concomitant downregulation of numerous genes, namely P2ry12, Tmem119, Olfml3, Egr1, Atf3, Jun, Fos, Mafb, Csf1r, Tgfb1 and Tgfbr1, which resulted in suppressed phagocytosis, was also found in SOD1 mice, a murine model of amyotrophic lateral sclerosis.”
From MicroRNAs as Regulators of Phagocytosis (2022) · cites this paper as [238]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Work from our lab and others found that miR-155, a glialenriched miRNA, is upregulated in the spinal cords of end-stage ALS model (SOD1 G93A ) mice and human autopsy (Koval et al., 2013;Butovsky et al., 2015).”
From MicroRNA Profiling Reveals Marker of Motor Neuron Disease in ALS Models (2017) · cites this paper as Butovsky et al., 2015
Experimental — accuracy not yet measured
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In the context of CNS damage resulting from Aβ, tau, SOD-1, or other pathologies, apoE is strongly upregulated in microglia coincident with the DAM or MGnD phenotype (Butovsky et al., 2015; Keren-Shaul et al., 2017; Krasemann et al., 2017; Parhizkar et al., 2019; Shi et al., 2017).”
From Selective removal of astrocytic APOE4 strongly protects against tau-mediated neurodegeneration and decreases synaptic phagocytosis by microglia (2021) · cites this paper as Butovsky et al., 2015
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“miRNAs are increasingly recognized as key regulators in ALS pathophysiology, including mitochondrial integrity and neuroinflammation, with miR-155 and miR-206 demonstrating pivotal roles in SOD1G93A models [48,49,50,51].”
From Modulation of the miR-485-3p/PGC-1α Pathway by ASO-Loaded Nanoparticles Attenuates ALS Pathogenesis (2026) · cites this paper as [49]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Support for beneficial outcomes associated with maintenance and/or restoration of homeostatic functions of microglia comes from the numerous studies targeting the members of this pathway, including Trem2,48,50–52 Tyrobp,53,54 and miR155.41,55”
From Microglial INPP5D limits plaque formation and glial reactivity in the PSAPP mouse model of Alzheimer's disease (2023) · cites this paper as [55]
The cited source says what the claim attributes to it.
In the citing paper
“As upregulation of miR-155 was also identified in human sporadic and familial amyotrophic lateral sclerosis”
From MicroRNAs as Regulators of Phagocytosis (2022) · cites this paper as [238]
The cited source says what the claim attributes to it.
In the citing paper
“Inhibiting miR-155 significantly delays disease progression in SOD1 G93A mice (Koval et al., 2013;Butovsky et al., 2015).”
From MicroRNA Profiling Reveals Marker of Motor Neuron Disease in ALS Models (2017) · cites this paper as Butovsky et al., 2015
In the citing paper
“The loss of homeostatic microglial proteins is visible in immunofluorescence double-staining of IBA1 and TMEM119 in terminally sick mice and mock-infected healthy control brains, and shows the reciprocal regulation of both proteins in prion disease (Figure 5A) [55,73,88,89,90,91].”
From Loss of Homeostatic Microglia Signature in Prion Diseases (2022) · cites this paper as [89]
In the citing paper
“during the course of many diseases, microglia lose their homeostatic molecular signature and functions26,84,114, such as their roles in synaptic plasticity115, and become chronically inflammatory116.”
From Microglial signatures and their role in health and disease (2018) · cites this paper as [84]
In the citing paper
“Tau, presenilin 2 and apolipoprotein E (ApoE) pathways were found to be activated in microglia in the SOD1 mouse, with Apoe being one of the transcripts that was the most significantly induced during disease progression.”
From Microglial signatures and their role in health and disease (2018) · cites this paper as [84]
In the citing paper
“Targeting miR-155 in microglia has shown to be a benefit in models of ALS84,195 and is currently being pursued as a possible therapeutic strategy.”
From Microglial signatures and their role in health and disease (2018) · cites this paper as [84]
In the citing paper
“This study validates miR-155 as a therapeutic target to modulate microglia in a mouse model and in human ALS.”
From Microglial signatures and their role in health and disease (2018) · cites this paper as [84]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Polazzi, E., Mengoni, I., Caprini, M., Peña‐Altamira, E., Kurtys, E., & Monti, B. (2012) · Neurosignals · doi:10.1159/000337115 · Cited by 9,023
Fate Mapping Analysis Reveals That Adult Microglia Derive from Primitive Macrophages
Ginhoux, F., Greter, M., Leboeuf, M., Nandi, S., See, P., Gokhan, S., Mehler, M. F., Conway, S. J., Ng, L. G., Stanley, E. R., et al. (2010) · Science · doi:10.1126/science.1194637 · Cited by 5,175
The HCV Life Cycle: In vitro Tissue Culture Systems and Therapeutic Targets
Gerold, G., & Pietschmann, T. (2014) · Digestive Diseases · doi:10.1159/000360830 · Cited by 4,871
Identification of a unique TGF-β–dependent molecular and functional signature in microglia
Butovsky, O., Jedrychowski, M. P., Moore, C. S., Cialic, R., Lanser, A. J., Gabriely, G., Koeglsperger, T., Dake, B., Wu, P. M., Doykan, C. E., et al. (2014) · Nature Neuroscience · doi:10.1038/nn.3599 · Cited by 2,543
Self-citationTreatment of HCV Infection by Targeting MicroRNA
Janssen, H. L. A., Reesink, H. W., Lawitz, E., Zeuzem, S., Rodriguez‐Torres, M., Patel, K., van der Meer, A. J., Patick, A. K., Chen, A. P., Zhou, Y., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1209026 · Cited by 2,262
Elmore, M. R. P., Najafi, A. R., Koike, M. A., Dagher, N. N., Spangenberg, E. E., Rice, R. A., Kitazawa, M., Matusow, B., Nguyen, H., West, B. L., et al. (2014) · Neuron · doi:10.1016/j.neuron.2014.02.040 · Cited by 1,968
MicroRNA-155 is induced during the macrophage inflammatory response
O'Connell, R. M., Taganov, K. D., Boldin, M. P., Cheng, G., & Baltimore, D. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0610731104 · Cited by 1,866
A tissue-specific atlas of mouse protein phosphorylation and expression
Huttlin, E. L., Jedrychowski, M. P., Elias, J. E., Goswami, T., Rad, R., Beausoleil, S. A., Villén, J., Haas, W., Sowa, M. E., & Gygi, S. P. (2010) · Cell · doi:10.1016/j.cell.2010.12.001 · Cited by 1,778
Self-citationOnset and Progression in Inherited ALS Determined by Motor Neurons and Microglia
Boillée, S., Yamanaka, K., Lobsiger, C. S., Copeland, N. G., Jenkins, N. A., Kassiotis, G., Kollias, G., & Cleveland, D. W. (2006) · Science · doi:10.1126/science.1123511 · Cited by 1,623
The P2Y12 receptor regulates microglial activation by extracellular nucleotides
Haynes, S. E., Hollopeter, G., Yang, G., Kurpius, D., Dailey, M. E., Gan, W.-B., & Julius, D. (2006) · Nature Neuroscience · doi:10.1038/nn1805 · Cited by 1,542
Flagged first, then by citations
Research works printed but not linked: 1
- Ponomarev ED, 2011, Nat Med, 64
Cited by
Sorted by citations
Items 101–200 of 358
Duffy, S. S., Keating, B. A., Perera, C. J., Lees, J. G., Tonkin, R. S., Makker, P. G. S., Carrive, P., Butovsky, O., & Moalem‐Taylor, G. (2019) · Journal of Neuroscience · doi:10.1523/jneurosci.1815-18.2019 · Cited by 86
Self-citationRegulating Endogenous Neural Stem Cell Activation to Promote Spinal Cord Injury Repair
Gilbert, E. A. B., Lakshman, N., Lau, K. S. K., & Morshead, C. M. (2022) · Cells · doi:10.3390/cells11050846 · Cited by 81
Hashemiaghdam, A., & Mroczek, M. (2020) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2020.577185 · Cited by 79
QSM is an imaging biomarker for chronic glial activation in multiple sclerosis lesions
Gillen, K. M., Mubarak, M., Park, C., Ponath, G. D., Zhang, S., Dimov, A., Levine-Ritterman, M., Toro, S., Huang, W., Amici, S. A., et al. (2021) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.51338 · Cited by 84
Gomes, C., Cunha, C., Nascimento, F., Ribeiro, J. A., Vaz, A. R., & Brites, D. (2019) · Molecular Neurobiology · doi:10.1007/s12035-018-1220-8 · Cited by 79
Loss of homeostatic microglial phenotype in CSF1R-related Leukoencephalopathy
Kempthorne, L., Yoon, H., Madore, C., Smith, S., Wszolek, Z. K., Rademakers, R., Kim, J., Butovsky, O., & Dickson, D. W. (2020) · Acta Neuropathologica Communications · doi:10.1186/s40478-020-00947-0 · Cited by 77
“It has been reported that peripheral administration of anti-miR155 in SOD1 mice reversed this abnormal phenotype of microglia and ameliorated the disease [6].”
BackgroundSelf-citationNoh, M., Kwon, H. S., Kwon, M., Nahm, M., Jin, H. K., Bae, J., & Kim, S. H. (2025) · Molecular Neurodegeneration · doi:10.1186/s13024-025-00867-4 · Cited by 94
Role of miR-155 in inflammatory autoimmune diseases: a comprehensive review
Xu, W.-D., Feng, S.-Y., & Huang, A.-F. (2022) · Inflammation Research · doi:10.1007/s00011-022-01643-6 · Cited by 76
Castranio, E. L., Hasel, P., Haure‐Mirande, J., Ramirez Jimenez, A. V., Hamilton, B. W., Kim, R. D., Glabe, C. G., Wang, M., Zhang, B., Gandy, S., et al. (2023) · Alzheimer's & Dementia · doi:10.1002/alz.12821 · Cited by 74
“41,55 However, as we have previously seen in our studies modulating Tyrobp expression, manipulation of molecules involved in immune/microglial function in either direction may result in detrimental or exacerbated pathological outcomes.”
Recent Updates on the Genetics of Amyotrophic Lateral Sclerosis and Frontotemporal Dementia
Kirola, L., Mukherjee, A., & Mutsuddi, M. (2022) · Molecular Neurobiology · doi:10.1007/s12035-022-02934-z · Cited by 79
Microglia in Ischemic Stroke: Pathogenesis Insights and Therapeutic Challenges
Shui, X., Chen, J., Fu, Z., Zhu, H., Tao, H., & Li, Z. (2024) · Journal of Inflammation Research · doi:10.2147/jir.s461795 · Cited by 80
Role of microRNAs in the regulation of innate immune cells under neuroinflammatory conditions
Cardoso, A. L., Guedes, J. R., & de Lima, M. C. P. (2015) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2015.09.001 · Cited by 71
Wang, C., Lu, J., Sha, X., Qiu, Y., Chen, H., & Yu, Z. (2023) · Experimental & Molecular Medicine · doi:10.1038/s12276-023-00935-z · Cited by 70
Purinergic contribution to amyotrophic lateral sclerosis
Volonté, C., Apolloni, S., Parisi, C., & Amadio, S. (2015) · Neuropharmacology · doi:10.1016/j.neuropharm.2015.10.026 · Cited by 73
Yelick, J., Men, Y., Jin, S., Seo, S., Espejo‐Porras, F., & Yang, Y. (2020) · Experimental Neurology · doi:10.1016/j.expneurol.2020.113414 · Cited by 68
Time course of bilateral microglial activation in a mouse model of laser-induced glaucoma
Ramirez, A. I., de Hoz, R., Fernández‐Albarral, J. A., Salobrar‐García, E., Rojas, B., Valiente‐Soriano, F. J., Avilés‐Trigueros, M., Villegas‐Pérez, M. P., Vidal‐Sanz, M., Triviño, A., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-61848-9 · Cited by 69
Campagno, K. E., Lu, W., Jassim, A. H., Albalawi, F., Cenaj, A., Tso, H., Clark, S. P., Sripinun, P., Gómez, N. M., & Mitchell, C. H. (2021) · Journal of Neuroinflammation · doi:10.1186/s12974-021-02251-7 · Cited by 68
Microglia: Friend and foe in tauopathy
Odfalk, K. F., Bieniek, K. F., & Hopp, S. C. (2022) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2022.102306 · Cited by 60
Microglia gone awry: linking immunometabolism to neurodegeneration
Afridi, R., Lee, W.-H., & Suk, K. (2020) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2020.00246 · Cited by 64
Dysregulated miRNAs as Biomarkers and Therapeutical Targets in Neurodegenerative Diseases
Gentile, G., Morello, G., Cognata, V. L., Guarnaccia, M., Conforti, F. L., & Cavallaro, S. (2022) · Journal of Personalized Medicine · doi:10.3390/jpm12050770 · Cited by 71
Alkhazaali-Ali, Z., Negah, S. S., Boroumand, A. R., & Tavakol‐Afshari, J. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.116899 · Cited by 69
Motor neuron-derived microRNAs cause astrocyte dysfunction in amyotrophic lateral sclerosis
Hoye, M. L., Regan, M. R., Jensen, L. A., Lake, A. M., Reddy, L. V., Vidensky, S., Richard, J.-P., Maragakis, N. J., Rothstein, J. D., Dougherty, J. D., et al. (2018) · Brain · doi:10.1093/brain/awy182 · Cited by 63
Rastegar-Moghaddam, S. H., Ebrahimzadeh-Bideskan, A., Shahba, S., Malvandi, A. M., & Mohammadipour, A. (2023) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-022-01200-z · Cited by 64
miR-129-5p: A key factor and therapeutic target in amyotrophic lateral sclerosis
Loffreda, A., Nizzardo, M., Arosio, A., Ruepp, M., Calogero, R., Volinia, S., Galasso, M., Bendotti, C., Ferrarese, C., Lunetta, C., et al. (2020) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2020.101803 · Cited by 58
The regulation of exosome function in the CNS: implications for neurodegeneration
Properzi, F., Ferroni, E., Poleggi, A., & Vinci, R. (2015) · Swiss Medical Weekly · doi:10.4414/smw.2015.14204 · Cited by 62
Wang, H.-T. A., Lee, J. D., Lee, K. M., Woodruff, T. M., & Noakes, P. G. (2017) · Skeletal Muscle · doi:10.1186/s13395-017-0128-8 · Cited by 61
Kumar, A., Henry, R. J., Stoica, B. A., Loane, D. J., Abulwerdi, G. A., Bhat, S. A., & Faden, A. I. (2018) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.118.253955 · Cited by 63
Immune mechanisms and shared immune targets in neurodegenerative diseases
Weiner, H. L. (2024) · Nature Reviews Neurology · doi:10.1038/s41582-024-01046-7 · Cited by 72
Self-citationAged Microglia in Neurodegenerative Diseases: Microglia Lifespan and Culture Methods
Yoo, H.-J., & Kwon, M. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.766267 · Cited by 65
Ma, S., Fan, L., Li, J., Zhang, B., & Yan, Z. (2019) · International Journal of Neuroscience · doi:10.1080/00207454.2019.1707817 · Cited by 57
Microglia as therapeutic target in central nervous system disorders
Fatoba, O., Itokazu, T., & Yamashita, T. (2020) · Journal of Pharmacological Sciences · doi:10.1016/j.jphs.2020.07.004 · Cited by 57
Marcuzzo, S., Bonanno, S., Kapetis, D., Barzago, C., Cavalcante, P., D’Alessandro, S., Mantegazza, R., & Bernasconi, P. (2015) · Molecular Brain · doi:10.1186/s13041-015-0095-0 · Cited by 57
Oussini, H. E., Bayer, H., Scekic‐Zahirovic, J., Vercruysse, P., Sinniger, J., Dirrig‐Grosch, S., Dieterle, S., Echaniz‐Laguna, A., Larmet, Y., Müller, K., et al. (2016) · Acta Neuropathologica · doi:10.1007/s00401-016-1534-4 · Cited by 62
Self-citationRegulatory function of microRNAs in microglia
Brites, D. M. T. O. (2020) · Glia · doi:10.1002/glia.23846 · Cited by 59
Microglial innate memory and epigenetic reprogramming in neurological disorders
Martins-Ferreira, R., Leal, B., Costa, P., & Ballestar, E. (2020) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2020.101971 · Cited by 55
Barbosa, M., Gomes, C., Sequeira, C., Gonçalves‐Ribeiro, J., Pina, C. C., Carvalho, L. A. R., Moreira, R., Vaz, S. H., Vaz, A. R., & Brites, D. M. T. O. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.634355 · Cited by 58
miR-155 Dysregulation and Therapeutic Intervention in Multiple Sclerosis
McCoy, C. E. (2017) · Advances in Experimental Medicine and Biology · doi:10.1007/978-981-10-5987-2_5 · Cited by 46
Vaz, A. R., Pinto, S., Ezequiel, C., Cunha, C., Carvalho, L. A., Moreira, R., & Brites, D. (2019) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2019.00109 · Cited by 55
The extensive role of miR-155 in malignant and non-malignant diseases
Gulei, D., Ráduly, L., Broseghini, E., Ferracin, M., & Berindan‐Neagoe, I. (2019) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2019.09.004 · Cited by 55
Scheffold, A., Holtman, I. R., Dieni, S., Brouwer, N., Katz, S.-F., Jebaraj, B. M. C., Kahle, P. J., Hengerer, B., Lechel, A., Stilgenbauer, S., et al. (2016) · Acta Neuropathologica Communications · doi:10.1186/s40478-016-0364-x · Cited by 53
MicroRNA-155 deletion reduces anxiety- and depressive-like behaviors in mice
Fonken, L. K., Gaudet, A. D., Gaier, K. R., Nelson, R. J., & Popovich, P. G. (2015) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2015.10.019 · Cited by 56
Evidence for an early innate immune response in the motor cortex of ALS
Jara, J. H., Genç, B., Stanford, M. J., Pytel, P., Roos, R. P., Weıntraub, S., Mesulam, M. M., Bigio, E. H., Miller, R. J., & Özdi̇nler, P. H. (2017) · Journal of Neuroinflammation · doi:10.1186/s12974-017-0896-4 · Cited by 58
Evaluation of monoacylglycerol lipase as a therapeutic target in a transgenic mouse model of ALS
Pasquarelli, N., Engelskirchen, M., Hanselmann, J., Endres, S., Porazik, C., Bayer, H., Buck, E., Karsak, M., Weydt, P., Ferger, B., et al. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.03.037 · Cited by 54
Abtin, M., Alivand, M. R., Khaniani, M. S., Bastami, M., Zaeifizadeh, M., & Derakhshan, S. M. (2018) · Journal of Cellular Biochemistry · doi:10.1002/jcb.26754 · Cited by 53
The microbiota restrains neurodegenerative microglia in a model of amyotrophic lateral sclerosis
Cox, L. M., Calcagno, N., Gauthier, C., Madore, C., Butovsky, O., & Weiner, H. L. (2022) · Microbiome · doi:10.1186/s40168-022-01232-z · Cited by 53
Self-citationThe multiple faces of extracellular vesicles released by microglia: Where are we 10 years after?
Gabrielli, M., Raffaele, S., Fumagalli, M., & Verderio, C. (2022) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2022.984690 · Cited by 55
M1 and M2 Functional Imprinting of Primary Microglia: Role of P2X7 Activation and miR-125b
Parisi, C., Napoli, G. D., Pelegrı́n, P., & Volonté, C. (2016) · Mediators of Inflammation · doi:10.1155/2016/2989548 · Cited by 51
Zhang, H., Chen, G., Qiu, W., Pan, Q., Chen, Y., Chen, Y., & Ma, X. (2020) · Journal of Neuroscience Research · doi:10.1002/jnr.24696 · Cited by 49
Li, C., Ren, J., Zhang, M., Wang, H., Fang, Y., Wu, J., & Tang, Y. (2022) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-022-04536-3 · Cited by 52
The Biogenesis of miRNAs and Their Role in the Development of Amyotrophic Lateral Sclerosis
Liu, J., Zhou, F., Guan, Y., Meng, F., Zhao, Z., Su, Q., Bao, W., Wang, X., Zhao, J., Huo, Z., et al. (2022) · Cells · doi:10.3390/cells11030572 · Cited by 55
Microglia Signatures: A Cause or Consequence of Microglia-Related Brain Disorders?
Mirarchi, A., Albi, E., & Arcuri, C. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252010951 · Cited by 52
Induction of miR-155 after Brain Injury Promotes Type 1 Interferon and has a Neuroprotective Effect
Harrison, E. B., Emanuel, K., Lamberty, B. G., Morsey, B. M., Li, M., Kelso, M. L., Yelamanchili, S. V., & Fox, H. S. (2017) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2017.00228 · Cited by 48
Dysregulation of a novel miR-1825/TBCB/TUBA4A pathway in sporadic and familial ALS
Helferich, A. M., Brockmann, S. J., Reinders, J., Deshpande, D., Holzmann, K., Brenner, D., Andersen, P. M., Petri, S., Thal, D. R., Michaelis, J., et al. (2018) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-018-2873-1 · Cited by 52
Phagocytosis of Apoptotic Cells Is Specifically Upregulated in ApoE4 Expressing Microglia in vitro
Muth, C., Hartmann, A., Falla, D. S., Glatzel, M., & Krasemann, S. (2019) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2019.00181 · Cited by 47
Self-citationGlial Purinergic Signaling in Neurodegeneration
Pietrowski, M. J., Gabr, A. A., Kozlov, S. O., Blum, D. L., Halle, A., & Carvalho, K. (2021) · Frontiers in Neurology · doi:10.3389/fneur.2021.654850 · Cited by 49
Overexpression of miR-124 in Motor Neurons Plays a Key Role in ALS Pathological Processes
Vaz, A. R., Vizinha, D., Morais, H. M. M., Colaço, A. R. A., Loch-Neckel, G., Barbosa, M., & Brites, D. M. T. O. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22116128 · Cited by 48
Patel, R. J., Brophy, C., Hickling, M., Neve, J., & Furger, A. (2019) · BMC Medical Genomics · doi:10.1186/s12920-019-0509-4 · Cited by 45
Klotho Is Neuroprotective in the Superoxide Dismutase (SOD1G93A) Mouse Model of ALS
Zeldich, E., Chen, C.-D., Boden, E., Howat, B., Nasse, J. S., Zeldich, D., Lambert, A. G., Yuste, A., Cherry, J. D., Mathias, R., et al. (2019) · Journal of Molecular Neuroscience · doi:10.1007/s12031-019-01356-2 · Cited by 46
Vassileff, N., Vella, L. J., Rajapaksha, H., Shambrook, M., Kenari, A. N., McLean, C., Hill, A. F., & Cheng, L. (2020) · Cells · doi:10.3390/cells9071709 · Cited by 48
Singh, A. K., Mishra, G., Maurya, A., Awasthi, R., Kumari, K., Thakur, A., Rai, A., Rai, G. K., Sharma, B., Kulkarni, G. T., et al. (2019) · Current Alzheimer Research · doi:10.2174/1567205016666190903102822 · Cited by 45
Toxoplasma gondii: A possible etiologic agent for Alzheimer's disease
Nayeri, T., Sarvi, S., Sharif, M., & Daryani, A. (2021) · Heliyon · doi:10.1016/j.heliyon.2021.e07151 · Cited by 46
Aloi, M. S., Prater, K. E., Sánchez, R. E. A., Beck, A., Pathan, J. L., Davidson, S., Wilson, A., Keene, C. D., de la Iglesia, H., Jayadev, S., et al. (2023) · Journal of Neuroinflammation · doi:10.1186/s12974-023-02745-6 · Cited by 43
Shi, H., Yin, Z., Koronyo, Y., Fuchs, D.-T. S., Sheyn, J., Davis, M. R., Wilson, J. W., Margeta, M. A., Pitts, K. M., Herron, S., et al. (2022) · Acta Neuropathologica Communications · doi:10.1186/s40478-022-01439-z · Cited by 45
Self-citationPham, J., Keon, M., Brennan, S. E., & Saksena, N. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21103464 · Cited by 45
The pro‐inflammatory microRNA miR‐155 influences fibrillar β‐Amyloid1‐42 catabolism by microglia
Aloi, M. S., Prater, K. E., Sopher, B., Davidson, S., Jayadev, S., & Garden, G. A. (2021) · Glia · doi:10.1002/glia.23988 · Cited by 43
The Possible Role of Neural Cell Apoptosis in Multiple Sclerosis
Kennedy, P. G. E., George, W., & Yu, X. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23147584 · Cited by 42
Apolloni, S., Fabbrizio, P., Amadio, S., Napoli, G., Verdile, V., Morello, G., Iemmolo, R., Aronica, E., Cavallaro, S., & Volonté, C. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01689 · Cited by 41
Christoforidou, E., Joilin, G., & Hafezparast, M. (2020) · Journal of Neuroinflammation · doi:10.1186/s12974-020-01822-4 · Cited by 44
RNA-Binding Proteins in the Regulation of miRNA Activity: A Focus on Neuronal Functions
Loffreda, A., Rigamonti, A., Barabino, S. M. L., & Lenzken, S. C. (2015) · Biomolecules · doi:10.3390/biom5042363 · Cited by 48
Katsumoto, A., de Miranda, A. S., Butovsky, O., Teixeira, A. L., Ransohoff, R. M., & Lamb, B. T. (2018) · Journal of Neuroinflammation · doi:10.1186/s12974-018-1075-y · Cited by 39
Self-citationPomper, N., Liu, Y., Hoye, M. L., Dougherty, J. D., & Miller, T. M. (2020) · Scientific Reports · doi:10.1038/s41598-020-61307-5 · Cited by 39
Chen, Y., Hong, T., Chen, F., Sun, Y., Wang, Y., & Cui, L. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.631827 · Cited by 40
Cieślak, M., Roszek, K., & Wujak, M. (2018) · Purinergic Signalling · doi:10.1007/s11302-018-9633-4 · Cited by 38
Non-coding RNAs: The Neuroinflammatory Regulators in Neurodegenerative Diseases
Jiang, H., Zhang, Y., Yue, J., Shi, Y., Xiao, B., Xiao, W., & Luo, Z. (2022) · Frontiers in Neurology · doi:10.3389/fneur.2022.929290 · Cited by 38
Zelic, M., Blazier, A. S., Pontarelli, F., LaMorte, M. J., Huang, J., Tasdemir-Yilmaz, O. E., Ren, Y., Ryan, S. K., Shapiro, C., Morel, C., et al. (2025) · Immunity · doi:10.1016/j.immuni.2025.02.024 · Cited by 44
Self-citationmiR155 regulation of behavior, neuropathology, and cortical transcriptomics in Alzheimer's disease
Readhead, B., Haure-Mirande, J.-V., Mastroeni, D., Audrain, M., Fanutza, T., Kim, S. H., Blitzer, R. D., Gandy, S., Dudley, J. T., & Ehrlich, M. E. (2020) · Acta Neuropathologica · doi:10.1007/s00401-020-02185-z · Cited by 37
Rahman, M. H., Rana, H. K., Peng, S., Kibria, M. G., Islam, M. Z., Mahmud, S. M. H., & Moni, M. A. (2021) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2021.104859 · Cited by 37
Role of noncoding RNA in vascular remodelling
Deng, L., Bradshaw, A. C., & Baker, A. H. (2016) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000336 · Cited by 36
MiRNA-155 regulates lymphangiogenesis in natural killer/T-cell lymphoma by targeting BRG1
Chang, Y., Cui, M., Fu, X., Zhang, L., Li, X., Li, L., Wu, J., Sun, Z., Zhang, X., Li, Z., et al. (2018) · Cancer Biology & Therapy · doi:10.1080/15384047.2018.1504721 · Cited by 36
The MicroRNA Centrism in the Orchestration of Neuroinflammation in Neurodegenerative Diseases
Nuzziello, N., & Liguori, M. (2019) · Cells · doi:10.3390/cells8101193 · Cited by 36
Wilson, H. E., Stanton, D. A., Montgomery, C., Infante, A. M., Taylor, M., Hazard-Jenkins, H. W., Pugacheva, E. N., & Pistilli, E. E. (2020) · npj Breast Cancer · doi:10.1038/s41523-020-0162-2 · Cited by 33
Pang, X., Chu, Y., Zhou, L., Chen, M., You, Y., Tang, Y., Yang, S., Zhang, H., Xiao, J., Deng, G., et al. (2023) · Journal of Neurochemistry · doi:10.1111/jnc.15987 · Cited by 33
Gut microbiota immune cross-talk in amyotrophic lateral sclerosis
Kaul, M., Mukherjee, D., Weiner, H. L., & Cox, L. M. (2024) · Neurotherapeutics · doi:10.1016/j.neurot.2024.e00469 · Cited by 36
Self-citationMicroglia modulate the cerebrovascular reactivity through ectonucleotidase CD39
Fu, Z., Ganesana, M., Hwang, P. H., Tan, X., Kinkaid, M. M., Sun, Y., Bian, E. J., Weybright, A., Chen, H., Sol‐Church, K., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-56093-5 · Cited by 41
Exosome-mediated crosstalk between microglia and neural stem cells in the repair of brain injury
Hou, B.-R., Jiang, C., Wang, Z.-N., & Ren, H. (2019) · Neural Regeneration Research · doi:10.4103/1673-5374.270302 · Cited by 34
Taming microglia: the promise of engineered microglia in treating neurological diseases
Luo, E. Y., & Sugimura, R. (2024) · Journal of Neuroinflammation · doi:10.1186/s12974-024-03015-9 · Cited by 35
Functional microglia neurotransmitters in amyotrophic lateral sclerosis
Volonté, C., Amadio, S., Fabbrizio, P., & Apolloni, S. (2019) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2019.04.014 · Cited by 34
Trageser, K. J., Smith, C., Herman, F. J., Ono, K., & Pasinetti, G. M. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.01298 · Cited by 31
Gadhave, D. G., Sugandhi, V. V., & Kokare, C. (2023) · Brain Research · doi:10.1016/j.brainres.2023.148674 · Cited by 33
RNA Deregulation in Amyotrophic Lateral Sclerosis: The Noncoding Perspective
Laneve, P., Tollis, P., & Caffarelli, E. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms221910285 · Cited by 32
Mechanism and Therapeutic Prospect of miRNAs in Neurodegenerative Diseases
Ma, Y.-M., & Zhao, L. (2023) · Behavioural Neurology · doi:10.1155/2023/8537296 · Cited by 34
Sex biology in amyotrophic lateral sclerosis
Zamani, A., Thomas, E., & Wright, D. K. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102228 · Cited by 35
DeLoach, A., Cozart, M. A., Kiaei, A., & Kiaei, M. (2015) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2015.1067197 · Cited by 36
Silencing a Multifunctional microRNA Is Beneficial for Stroke Recovery
Roitbak, T. (2018) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2018.00058 · Cited by 31
Circulating MicroRNAs as Potential Noninvasive Biomarkers of Spontaneous Intracerebral Hemorrhage
Фанилевич, Г. И., Yang, G., Sun, J., Beylerli, O., Chen, X., Zhang, D., Zhao, B., Zhang, R., Sun, Z., Yang, Q., et al. (2019) · World Neurosurgery · doi:10.1016/j.wneu.2019.09.016 · Cited by 31
A hidden threshold in motor neuron gene networks revealed by modulation of miR-218 dose
Amin, N. D., Senturk, G., Costaguta, G., Driscoll, S. P., O’Leary, B., Bonanomi, D., & Pfaff, S. L. (2021) · Neuron · doi:10.1016/j.neuron.2021.07.028 · Cited by 29
Gomes, C., Sequeira, C., Likhite, S. B., Dennys, C. N., Kolb, S. J., Shaw, P. J., Vaz, A. R., Kaspar, B. K., Meyer, K., & Brites, D. M. T. O. (2022) · Cells · doi:10.3390/cells11071186 · Cited by 32
Obora, K., Onodera, Y., Takehara, T., Frampton, J. P., Hasei, J., Ozaki, T., Teramura, T., & Fukuda, K. (2017) · Scientific Reports · doi:10.1038/srep43604 · Cited by 30
Greco, R., Demartini, C., Zanaboni, A. M., Blandini, F., Amantea, D., & Tassorelli, C. (2017) · Journal of Neuroscience Research · doi:10.1002/jnr.24101 · Cited by 29
Rahman, M. H., Peng, S., Hu, X., Chen, C., Uddin, S., Quinn, J. M. W., & Moni, M. A. (2019) · IEEE Access · doi:10.1109/access.2019.2960037 · Cited by 30
Metadata
- Authors
- Butovsky, O., Jedrychowski, M. P., Cialic, R., Krasemann, S., Murugaiyan, G., Fanek, Z., Greco, D. J., Wu, P. M., Doykan, C. E., Kiner, O., Lawson, R. J., Frosch, M. P., Pochet, N., Fatimy, R. E., Krichevsky, A. M., Gygi, S. P., Lassmann, H., Berry, J., Cudkowicz, M. E., & Weiner, H. L.
- Affiliations
- Brigham and Women's Hospital (US)
- Harvard University (US)
- University Medical Center Hamburg-Eppendorf (DE)
- Broad Institute (US)
- Medical University of Vienna (AT)
- Corresponding author
- Butovsky, Oleg
- ORCID
- Venue
- Annals of Neurology
- Publisher
- Wiley
- Published
- 2014-11-27
- Volume
- 77
- Issue
- 1
- Pages
- 75-99
- ISSN
- 0364-5134 (ISSN-L)
- 1531-8249
- PMC
- PMC4432483
- OpenAlex
- W1545421865
- Cited by
- 358
- References
- 63
- Citations by year
- 2026: 10 · 2025: 22 · 2024: 33 · 2023: 31 · 2022: 46 · 2021: 32 · 2020: 33 · 2019: 29 · 2018: 41 · 2017: 35 · 2016: 26 · 2015: 20
- FWCI
- 17.60
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Annals of Neurology (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health (NS088137)
- U.S. Department of Defense (AL120029)
- Amyotrophic Lateral Sclerosis Association (IV78RI, ALSA2087)
- National Multiple Sclerosis Society
- The Nancy Davis Foundation for Multiple Sclerosis
- Edward N. & Della L. Thome Memorial Foundation
- Topics
- Health Sciences › Medicine › Clinical Neurology › Amyotrophic Lateral Sclerosis Research
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Health Sciences › Medicine › Clinical Neurology › Multiple Sclerosis Research Studies
- Keywords
- miR-155, amyotrophic lateral sclerosis, microglia, microglial homeostasis, apolipoprotein E, microglial phagocytosis, microglial survival, therapeutic target, familial ALS, sporadic ALS
- MeSH terms
- Aged, Amyotrophic Lateral Sclerosis, Animals, Apolipoproteins E, Cells, Cultured, Disease Models, Animal, Female, Gene Expression Regulation, Hippocampus, Humans, Male, Mice, Transgenic, Middle Aged, Monocytes, Neurons, Phagocytosis, Spinal Cord, Superoxide Dismutase, Transforming Growth Factor beta, Microglia, Oligoribonucleotides, Antisense, MicroRNAs, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
